American pharmaceutical manufacturer takes advantage of the medical reform to rise crazily in price The amount of the increase occupies the top in recent years

American pharmaceutical manufacturer takes advantage of the medical reform to rise crazily in price The amount of the increase occupies the top in recent years
Assault and rise the American pharmaceutical manufacturer in price and cause public wrath before the medical reform
Zhang Jin
The medical reform scheme that US President Barach's Palestinian horse pursued has already been passed by Congress House of Representatives, only one step away to final realization. Although American pharmaceutical manufacturer offers the prescribed medicine discount valued at 80 billion dollars in commitment the following 10 years, but rise crazily in price when the medical reform has not implemented yet, the amount of the increase occupies the top in recent years.
Report of the 16th of U.S.A. " the New York Times ", a latest research report reveals, U.S.A.'s medical insurance system covers the brand medicines average price that the crowd most often uses and goes up by 9.3% in the past year, achive the top of next amount of the increase of 1992.
The research initiate by the intersection of U.S.A. and retired association, trust Minnesota the intersection of university and the intersection of medicine and Stephen, Professor of economics, to give up the favor to step and implement. This amount of the increase means the American medicines expenses bill will have another more more than 10 billion dollars, the medicines expenses total value of this year presses on towards 300 billion dollars.
Give up the favor and step and say: "We find, whenever the relevant important bill will be implemented soon, the medicine price will thereupon swell fiercely too. "
Analysts of Credit Swisse medicines trade Catherine and Arnold can work out the similar result. Her research reveals, by September 30 this year, the American medicine price goes up by 8.7% on average in 12 months, run high one most since the 2004.
Arnold analyzes, the pharmaceutical manufacturer predicts the medicine price may be controlled after the medical reform is implemented, the trade integrated environment is unfavorable, therefore choose to rise in price this time. "If want to rise in price, it is the best opportunity now, because will think next year and the year after next that it is more difficult to rise in price. "
The medicine price rises sharply and lets a lot of people feel discontented. New York resident Eric and White comes out from the pharmacy, complain to the reporter: "The pharmaceutical manufacturer asks an exorbitant price, this is unfair. "
White is a small-scale boss of jeweler's shop in the district of New York queen. He says, in the depressed period of this economy, his jewel price is reduce by at least 40% in order to keep the travellered. By contrast, but rise appears in the medicine price. Though there is medical insurance, he still needs to cost 110 dollars to buy two kinds and resist the allergic medicine every month.
" what a office I am, " White shakes the head and says " I must take medicine. "
Some critic say pharmacy industry agree prescribed medicine discount supplying government and the elderly with 80 billion dollars of value under the following 10 years, but promote the medicine price by a wide margin at the same time, let the result of this commitment give a great discount.
The American consumer alliance senior sanitarian Steven and Findlay says: "Pharmaceutical manufacturer, through rise in price easy to earn, answer those 80 billion dollars, because they will earn more. "
Criticize in the face of the expert and people are discontented, the pharmaceutical manufacturer explains, the reason of rising in price of medicines is abundant, do not rush before health care reform is implemented " Loot a burning house " .
Some manufacturers say, because some medicines patents sold fast most will expire soon in the following several years of time limit, they have to raise the medicine price and guarantee the essential income, in order to put into research and development of new medicine. Medical spokesman of Merck company of trade giant Ron and Rogers says: "The products price adjustment of our company totally has nothing to do with health care reform. "
U.S.A. and medical research and Kenya, Vice President of production associaton Johnson criticize, give up favor, step, influenced by political factor the intersection of U.S.A. and retired research that support make of association.
Johnson says: "According to world outlook that the retired association of U.S.A. distorts, medicines are usually regarded as a kind of consumption, but not deposit money. In fact, medicines can reduce unnecessary hospital treatment, help avoids expensive medical surgery, can control and prevent chronic disease better. "
(Xinhua News Agency's special draft)

|